Literature DB >> 33635317

SARS-CoV-2 Vaccines.

C Buddy Creech1, Shannon C Walker1, Robert J Samuels1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33635317     DOI： 10.1001/jama.2021.3199

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  125 in total

Review 1.  SARS-CoV-2 pathogenesis.

Authors:  Mart M Lamers; Bart L Haagmans
Journal:  Nat Rev Microbiol       Date:  2022-03-30       Impact factor: 60.633

2.  Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination.

Authors:  Franziska Neumann; Ruben Rose; Janine Römpke; Olaf Grobe; Thomas Lorentz; Helmut Fickenscher; Andi Krumbholz
Journal:  Vaccines (Basel)       Date:  2021-06-25

3.  Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020.

Authors:  Abram L Wagner; Sherri Sheinfeld Gorin; Matthew L Boulton; Brian A Glover; Jeffrey D Morenoff
Journal:  Hum Vaccin Immunother       Date:  2021-05-17       Impact factor: 3.452

4.  Humoral immune response after different SARS-CoV-2 vaccination regimens.

Authors:  Ruben Rose; Franziska Neumann; Olaf Grobe; Thomas Lorentz; Helmut Fickenscher; Andi Krumbholz
Journal:  BMC Med       Date:  2022-01-21       Impact factor: 8.775

5.  Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.

Authors:  Lee M Greenberger; Larry A Saltzman; Jonathon W Senefeld; Patrick W Johnson; Louis J DeGennaro; Gwen L Nichols
Journal:  Cancer Cell       Date:  2021-07-22       Impact factor: 31.743

6.  Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China.

Authors:  Jia Lu; Xiaosa Wen; Qi Guo; Mengdi Ji; Felicia Zhang; Abram L Wagner; Yihan Lu
Journal:  Vaccines (Basel)       Date:  2021-05-07

7.  Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?

Authors:  Giuseppe Lippi; Brandon Michael Henry; Mario Plebani
Journal:  Diagnostics (Basel)       Date:  2021-05-25

8.  The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2.

Authors:  Yoko Kurihara; Yoshihiko Kiyasu; Yusaku Akashi; Yuto Takeuchi; Kenji Narahara; Sunao Mori; Tomonori Takeshige; Shigeyuki Notake; Atsuo Ueda; Koji Nakamura; Hiroichi Ishikawa; Hiromichi Suzuki
Journal:  J Infect Chemother       Date:  2021-07-13       Impact factor: 2.211

9.  Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination.

Authors:  Vincenzo Puro; Concetta Castilletti; Chiara Agrati; Delia Goletti; Sara Leone; Alessandro Agresta; Eleonora Cimini; Eleonora Tartaglia; Rita Casetti; Francesca Colavita; Silvia Meschi; Giulia Matusali; Daniele Lapa; Saeid Najafi Fard; Alessandra Aiello; Chiara Farrone; Paola Gallì; Maria Rosaria Capobianchi; Giuseppe Ippolito
Journal:  Vaccines (Basel)       Date:  2021-06-08

10.  Is it possible to ensure COVID19 vaccine supply by using plants?

Authors:  Anirban Bhar
Journal:  Nucleus (Calcutta)       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.